학술논문
P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 566-567 (2022)
Subject
Language
English
ISSN
2572-9241